Clinical and Biochemical Characteristics of Diabetes Ketoacidosis in a Tertiary Hospital in Riyadh

被引:8
作者
Almalki, Mussa H. [1 ,2 ]
Buhary, Badurudeen Mahmood [1 ]
Khan, Shawana Abdulhamid [1 ]
Almaghamsi, Abdulrahman [1 ]
Alshahrani, Fahad [3 ]
机构
[1] King Fahad Med City, Obes Endocrine & Metab Ctr, Riyadh, Saudi Arabia
[2] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, King Fahad Med City, Riyadh, Saudi Arabia
[3] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, King Abdulaziz Med City, Riyadh, Saudi Arabia
关键词
diabetes; diabetic ketoacidosis; presenting symptoms; precipitating cause;
D O I
10.4137/CMED.S39639
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes is the fifth leading cause of death worldwide. Diabetic ketoacidosis (DKA) is a life-threatening acute complication of diabetes. The aim of this study is to investigate the clinical and biochemical characteristics of DKA among 400 patients admitted to hospital, most of whom had type 1 diabetes (n = 372; 93%). Vomiting (n = 319; 79.8%), nausea (n = 282; 70.5%), and abdominal pain (n = 303; 75.8%) were the presenting symptoms most commonly experienced by the patients. Tachycardia was the most common clinical sign noted in the patients on admission (n = 243; 61.8%). The predominant precipitating cause of DKA was noncompliance to an insulin regimen (n = 215; 54.2%). Recurrent DKA admissions in type 1 diabetes patients was higher than those with type 2 diabetes (n = 232 versus n = 9, respectively; P = 0.002). Recurrent DKA admissions in female patients were higher than in male patients (n = 167 versus n = 74, respectively; P = 0.002). Continued diabetic education (given to n = 384; 94%) and counseling on the importance of adhering to the recommended medical regime, addressing the social and cultural barriers that precipitate DKA, as well as the provision of timely medical attention may greatly reduce DKA episodes and their associated complications.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 20 条
  • [1] Al-Nozha MM, 2004, SAUDI MED J, V25, P1603
  • [2] Al-Rubeaan KA, 2011, EUR REV MED PHARMACO, V15, P1202
  • [3] Alourfi Zaynab, 2015, Avicenna J Med, V5, P11, DOI 10.4103/2231-0770.148503
  • [4] [Anonymous], 2004, REV MAL RESP 2, V21, pS3
  • [5] Centers for Disease Control and Prevention, 2013, AG ADJ HOSP DISCH RA
  • [6] Elmehdawi R. R., 2010, Eastern Mediterranean Health Journal, V16, P292
  • [7] THE EPIDEMIOLOGY OF DIABETIC ACIDOSIS - A POPULATION-BASED STUDY
    FAICH, GA
    FISHBEIN, HA
    ELLIS, SE
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1983, 117 (05) : 551 - 558
  • [8] Management of adult diabetic ketoacidosis
    Gosmanov, Aidar R.
    Gosmanova, Elvira O.
    Dillard-Cannon, Erika
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 255 - 264
  • [9] JOHNSON DD, 1980, MAYO CLIN PROC, V55, P83
  • [10] Kitabchi Abbas E, 2004, Diabetes Care, V27 Suppl 1, pS94